Correvio Pharma Corp (CORV) Stock Price, Quote, News and Overview
NASDAQ:CORV - Nasdaq -
CORV Quote, Performance and Key Statistics
0.4199
+0 (+0.82%)
The current stock price of CORV is 0.4199 null. In the past month the price increased by 1.57%. In the past year, price decreased by -81.25%.
About CORV
Company Profile
Correvio Pharma Corp. operates as a pharmaceutical company. It develops and discovers cardiovascular drugs for the treatment of atrial arrhythmia, congestive heart failure and bacterial skin infections. The company's product portfolio includes BRINAVESS(R), AGGRASTAT(R), ESMOCARD(R), ESMOCARDLYO(R), EXEMBOL(R) and XYDALBA(TM). Correvio Pharma Corp., formerly known as Correvio Pharma Corp., is based in Vancouver, Canada.
Company Info
Correvio Pharma Corp
1441 Creekside Drive 6th Floor
Vancouver A1 V6J 4S7
CEO: Mark Corrigan
Phone: 604-677-6905
Correvio Pharma Corp / CORV FAQ
What is the stock price of Correvio Pharma Corp today?
The current stock price of CORV is 0.4199 null. The price increased by 0.82% in the last trading session.
What is the ticker symbol for Correvio Pharma Corp stock?
The exchange symbol of Correvio Pharma Corp is CORV and it is listed on the Nasdaq exchange.
On which exchange is CORV stock listed?
CORV stock is listed on the Nasdaq exchange.
What is Correvio Pharma Corp worth?
Correvio Pharma Corp (CORV) has a market capitalization of 27.79M null. This makes CORV a Nano Cap stock.
What are the support and resistance levels for Correvio Pharma Corp (CORV) stock?
Correvio Pharma Corp (CORV) has a support level at 0.42 and a resistance level at 0.43. Check the full technical report for a detailed analysis of CORV support and resistance levels.
Should I buy Correvio Pharma Corp (CORV) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of CORV, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of CORV, evaluating the profitability, health, valuation and growth aspects
- Correvio Pharma Corp (CORV) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- Correvio Pharma Corp (CORV) Sales and EPS estimates to see what analysts future expectations are.
- Correvio Pharma Corp (CORV) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- Correvio Pharma Corp (CORV) Insider and Institutional Ownership to learn about the owners and their transactions.
- Correvio Pharma Corp (CORV) Stock Chart to make your own analysis
- Correvio Pharma Corp (CORV) Latest news and press-releases to stay up to date.
Does Correvio Pharma Corp (CORV) stock pay dividends?
CORV does not pay a dividend.
What is the Price/Earnings (PE) ratio of Correvio Pharma Corp (CORV)?
Correvio Pharma Corp (CORV) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.79).
CORV Technical Analysis
ChartMill assigns a technical rating of 5 / 10 to CORV. When comparing the yearly performance of all stocks, CORV is a bad performer in the overall market: 95.72% of all stocks are doing better.
CORV Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to CORV. Both the profitability and financial health of CORV have multiple concerns.
CORV Financial Highlights
Over the last trailing twelve months CORV reported a non-GAAP Earnings per Share(EPS) of -0.79. The EPS increased by 11.24% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | -107.81% | ||
| ROA | -59.26% | ||
| ROE | N/A | ||
| Debt/Equity | 21.5 |
CORV Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 60% to CORV. The Buy consensus is the average rating of analysts ratings from 3 analysts.